Novel production of a new oral vaccine for COVID-19 with a recombinant Bacillus subtilis strain
- Funded by Natural Sciences and Engineering Research Council of Canada (NSERC)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$36,176Funder
Natural Sciences and Engineering Research Council of Canada (NSERC)Principal Investigator
Simon BarnabéResearch Location
CanadaLead Research Institution
Québec à Trois-RivièresResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
Innovation
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Medical and health sciences